Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Jun. 30, 2016
Current Assets:
Cash and cash equivalents	$ 21,898,468	$ 13,203,625
Marketable securities	24,071,004	37,424,221
Accounts receivable, net of allowance for doubtful accounts of $21,985 at March 31, 2017 and $74,546 at June 30, 2016	820,787	513,992
Inventory	685,615	350,524
Other receivables	111,190	236,768
Prepaid expenses	763,640	1,038,155
Other current assets	140,353	183,820
Total current assets	48,491,057	52,951,105
Property and equipment, net of accumulated depreciation of $29,268,601 and $28,637,606 at March 31, 2017 and June 30, 2016, respectively	4,168,465	3,969,163
Other long-term assets	30,000	30,000
Total Assets	52,689,522	56,950,268
Current Liabilities:
Accounts payable and accrued expenses	19,597,698	15,188,189
Warrant liabilities	65,199,603
Deferred revenues	192,142	235,372
Total current liabilities	84,989,443	15,423,561
Convertible senior notes – net of unamortized debt issuance costs of $2,098,236 at March 31, 2017 and $2,645,602 at June 30, 2016	97,901,764	97,354,398
Other liabilities	1,717,338	1,699,276
Commitments and Contingencies (Note 12)
Stockholders' Deficit:
Preferred stock, $.01 par value; authorized 10,000,000 shares; no shares issued and outstanding at March 31, 2017 and June 30, 2016
Common stock, $.01 par value; authorized 155,000,000 shares; issued 109,604,620 shares and outstanding 109,569,895 shares at March 31, 2017; issued 95,867,298 shares and outstanding 95,832,573 shares at June 30, 2016	1,096,045	958,672
Capital contributed in excess of par	336,782,556	311,320,651
Treasury stock, at cost: 34,725 shares at March 31, 2017 and at June 30, 2016	(458,370)	(458,370)
Accumulated deficit	(468,456,204)	(368,504,954)
Accumulated other comprehensive loss	(126,146)	(132,226)
Total Immunomedics, Inc. stockholders' deficit	(131,162,119)	(56,816,227)
Noncontrolling interest in subsidiary	(756,904)	(710,740)
Total stockholders’ deficit	(131,919,023)	(57,526,967)
Total Liabilities and Stockholders' Deficit	$ 52,689,522	$ 56,950,268

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.